Form 4: Myomo Director Thomas Crowley Jr. Receives Significant RSU Grant, Aligning Interests with Shareholders
Insider Transaction Report
Myomo, Inc. Director Thomas Aloysius Crowley Jr. was granted 29,720 Restricted Stock Units (RSUs) under the company's 2018 Stock Option and Incentive Plan, vesting quarterly starting September 11, 2025.
Summary
- Thomas Aloysius Crowley Jr., a Director of Myomo, Inc. (MYO), was granted 29,720 Restricted Stock Units (RSUs) on June 11, 2025.
- These RSUs were granted at a price of $0 per unit under the Issuer's 2018 Stock Option and Incentive Plan.
- The RSUs are scheduled to vest in four equal quarterly installments, with the first vesting date on September 11, 2025.
- Following this transaction, Mr. Crowley's direct beneficial ownership of common stock increased to 71,748 shares.
- A Limited Power of Attorney was executed on May 15, 2025, by Thomas A. Crowley, appointing Paul Gudonis, David Henry, and Amy Vetrano-Palmer as attorneys-in-fact to handle SEC filings on his behalf.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as the RSU grant aligns the director's interests with shareholders and is a standard compensation practice, indicating stability in governance. The potential for minor dilution is generally offset by the incentive for long-term performance and retention of key personnel.
Positives
- The grant of Restricted Stock Units to a director aligns the director's financial interests with those of the shareholders, as the value of the compensation is directly tied to the company's stock performance.
- The structured vesting schedule provides an incentive for long-term commitment and sustained performance from the director, contributing to corporate stability.
Negatives
- The issuance of new RSUs, upon their eventual vesting, can lead to a slight dilution of existing shareholder equity, although the impact from this specific grant is likely minimal.
Risks
- The Limited Power of Attorney includes an indemnification clause where the reporting person agrees to indemnify the attorneys-in-fact and the Company from any demand, damage, loss, cost, or expense arising from false or misleading information provided by the reporting person, highlighting a potential risk of inaccurate information submission.
Future Outlook
The granted Restricted Stock Units are scheduled to vest in four equal quarterly installments beginning on September 11, 2025, indicating a future compensation schedule for the director and a continued alignment of interests.
Management Comments
- "Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in four equal quarterly installments beginning on September 11, 2025."
- "The undersigned hereby constitutes and appoints each of Paul Gudonis, David Henry and Amy Vetrano-Palmer, signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact..."
Industry Context
This Form 4 filing reflects a routine equity compensation event for a director, which is a common practice across publicly traded companies to align management and board interests with shareholder value. Such grants are standard within the medical technology and rehabilitation device industry, where attracting and retaining experienced leadership is crucial for innovation and market penetration.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Thomas A. Crowley, a director, has granted a Limited Power of Attorney to Paul Gudonis, David Henry, and Amy Vetrano-Palmer to execute and file SEC forms (Form ID, 3, 4, 5, Schedules 13D/13G) on his behalf. This action streamlines compliance with Section 16(a) of the Securities Exchange Act of 1934. | 05/15/2025 | This delegation enhances efficiency and ensures timely compliance with SEC reporting requirements for insider transactions, reducing administrative burden on the director and ensuring regulatory adherence. |
Related Party Transactions
- The grant of 29,720 Restricted Stock Units to Thomas Aloysius Crowley Jr., a director of Myomo, Inc., constitutes a related party transaction as it involves compensation from the company to a member of its board of directors.
Stakeholder Impact
- **Shareholders**: Potential for minor dilution upon the vesting of RSUs, but also improved alignment of the director's interests with shareholder value through equity-based compensation, incentivizing long-term company performance.
- **Employees**: While not directly impacted by this specific grant, the existence of the 2018 Stock Option and Incentive Plan suggests a broader framework for employee incentives, which can positively impact morale and retention.
Next Steps
- The granted Restricted Stock Units will vest in four equal quarterly installments, with the first installment vesting on September 11, 2025.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Execution date of the Limited Power of Attorney by Thomas A. Crowley. |
| 06/11/2025 | Date of grant of 29,720 Restricted Stock Units (RSUs) to Thomas Aloysius Crowley Jr. |
| 06/13/2025 | Signature date of the Form 4 filing by David A. Henry, Attorney-in-Fact. |
| 09/11/2025 | First vesting date for the granted Restricted Stock Units, with subsequent vesting in three equal quarterly installments thereafter. |
Recommendation
holdKeywords
Myomo, MYO, Restricted Stock Units, RSU, Insider Transaction, SEC Form 4, Director Compensation, Equity Grant, Stock Option and Incentive Plan, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.